<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="perry" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">perry</book-part-id>
      <title-group>
        <title>Perry Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wszolek</surname>
            <given-names>Zbigniew</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology<break/>Mayo Clinic<break/>Jacksonville, Florida</aff>
          <email>wszolek.zbigniew@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Konno</surname>
            <given-names>Takuya</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology<break/>Mayo Clinic<break/>Jacksonville, Florida</aff>
          <email>konno.takuya@mayo.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>30</day>
          <month>9</month>
          <year>2010</year>
        </date>
        <date date-type="updated">
          <day>29</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="perrault" document-type="chapter">Perrault Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="peters-plus" document-type="chapter">Peters Plus Syndrome</related-object>
      <abstract id="perry.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Perry syndrome is characterized by parkinsonism, hypoventilation, depression, and weight loss. The mean age at onset is 49 years; the mean disease duration is five years. Parkinsonism and psychiatric changes (depression, apathy, character changes, and withdrawal) tend to occur early; severe weight loss and hypoventilation manifest later.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of Perry syndrome is established in a proband with all four of the cardinal features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Early-onset familial parkinsonism</p>
            </list-item>
            <list-item>
              <p>Mood/personality changes</p>
            </list-item>
            <list-item>
              <p>Weight loss</p>
            </list-item>
            <list-item>
              <p>Central hypoventilation</p>
            </list-item>
          </list>
          <p>Identification of a heterozygous <italic toggle="yes">DCTN1</italic> pathogenic variant on molecular genetic testing confirms the diagnosis if clinical features are inconclusive.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Dopaminergic therapy (particularly carbidopa/levodopa) should be considered in all individuals with significant parkinsonism. Although response to levodopa is often poor, some individuals may have long-term benefit. At times large doses of carbidopa/levodopa are required. Ventilation support may prolong life expectancy and improve quality of life. Those individuals with psychiatric manifestations may benefit from antidepressants and psychiatric care. Weight loss is managed with appropriate dietary changes.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Adequate caloric intake to prevent weight loss.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine evaluation of weight and calorie intake, respiratory function (particularly at night or during sleep), motor function, and mood/personality changes.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Central respiratory depressants (e.g., benzodiazepines, alcohol, narcotics).</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Perry syndrome is inherited in an autosomal dominant manner. The proportion of cases attributed to a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. Each child of an individual with Perry syndrome has a 50% chance of inheriting the pathogenic variant. Prenatal testing is possible for families in which the pathogenic variant has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="perry.Diagnosis">
        <title>Diagnosis</title>
        <sec id="perry.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Perry syndrome <bold>should be suspected</bold> in individuals with these cardinal clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Early-onset familial parkinsonism</p>
            </list-item>
            <list-item>
              <p>Mood/personality changes (depression, apathy, withdrawal, disinhibition)</p>
            </list-item>
            <list-item>
              <p>Weight loss</p>
            </list-item>
            <list-item>
              <p>Central hypoventilation</p>
            </list-item>
          </list>
          <p>Diagnostic criteria were previously proposed prior to the availability of molecular and immunohistochemistry testing [<xref ref-type="bibr" rid="perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</xref>]. However, with the availability of molecular genetic testing they are no longer crucial for the diagnosis.</p>
        </sec>
        <sec id="perry.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of Perry syndrome <bold>can be established</bold> in a proband who has ALL of the above cardinal features.</p>
          <p>Identification of a heterozygous <italic toggle="yes">DCTN1</italic> pathogenic variant on molecular genetic testing confirms the diagnosis if clinical features are inconclusive (see <xref ref-type="table" rid="perry.T.molecular_genetic_testing_used_i">Table 1</xref>). Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Perform sequence analysis of <italic toggle="yes">DCTN1.</italic></p>
              <p>Note: Since Perry syndrome occurs through a dominant-negative mechanism (see <xref ref-type="sec" rid="perry.Molecular_Genetics">Molecular Genetics</xref>) and large intragenic deletion or duplication has not been reported, testing for intragenic deletions or duplication is unlikely to identify a disease-causing variant. Detailed genetic studies for intragenic deletions or duplications have not been conducted.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">DCTN1</italic> and other genes of interest (see <xref ref-type="sec" rid="perry.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">DCTN1</italic>) fails to confirm a diagnosis in an individual with features of Perry syndrome. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="perry.T.molecular_genetic_testing_used_i" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Perry syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">DCTN1</italic>
                  </td>
                  <td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">21/21 (100%)&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="perry.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="perry" object-id="perry.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="perry.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="perry.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="perry.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="perry.TF.1.4">
                <label>4. </label>
                <p>All 21 probands with Perry syndrome reported thus far have one of nine <italic toggle="yes">DCTN1</italic> pathogenic variants located in exon 2 (see <xref ref-type="table" rid="perry.T.dctn1_selected_pathogenic_varian">Table 2</xref>) [<xref ref-type="bibr" rid="perry.REF.farrer.2009.163">Farrer et al 2009</xref>, <xref ref-type="bibr" rid="perry.REF.newsway.2010.767">Newsway et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.ohshima.2010.612">Ohshima et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.wider.2010.149">Wider et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.aji.2013.117">Aji et al 2013</xref>, <xref ref-type="bibr" rid="perry.REF.araki.2014.1201">Araki et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.caroppo.2014.208">Caroppo et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.chung.2014.388">Chung et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.pretelt.2014.620">Pretelt et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.tacik.2014.884">Tacik et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.barreto.2015.s304">Barreto et al 2015</xref>, <xref ref-type="bibr" rid="perry.REF.gustavsson.2016.56">Gustavsson et al 2016</xref>].</p>
              </fn>
              <fn id="perry.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="perry.TF.1.6">
                <label>6. </label>
                <p>Since Perry syndrome occurs through a dominant-negative mechanism and large intragenic deletion or duplication has not been reported, testing for intragenic deletions or duplication is unlikely to identify a disease-causing variant.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="perry.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="perry.Clinical_Description">
          <title>Clinical Description</title>
          <p>The cardinal findings of Perry syndrome are parkinsonism, hypoventilation, depression, and weight loss [<xref ref-type="bibr" rid="perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</xref>, <xref ref-type="bibr" rid="perry.REF.wider.2010.149">Wider et al 2010</xref>]. The mean age at onset is 49 years (range: 35-70 years) and the mean disease duration is five years (range: 2-14 years). Psychiatric (depression, apathy, character changes, withdrawal) and motor (parkinsonism) symptoms tend to occur early, whereas severe weight loss and hypoventilation manifest later. In most affected persons the reported cause/circumstance of death relates to sudden death/hypoventilation or suicide [<xref ref-type="bibr" rid="perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</xref>].</p>
          <p><bold>Parkinsonism.</bold> Most affected individuals present with akinetic-rigid and rather symmetric parkinsonism that is less severe than that found in Parkinson disease. When present, tremor is often postural; however, typical rest tremor has been reported.</p>
          <p><bold>Hypoventilation.</bold> Alveolar hypoventilation manifests particularly at night or during sleep with tachypnea alternating with normal respiratory cycles, leading to frequent awakenings. Polysomnographic recordings show that hypoxemia and hypercapnia are of central origin; that is, there is no obstructive or structural respiratory tract abnormality. One detailed autopsy study demonstrated significant neuronal loss in regions critical for respiratory drive (ventrolateral medulla [pre-B&#x000f6;tzinger complex] and dorsal raphe nucleus), which may account for central hypoventilation [<xref ref-type="bibr" rid="perry.REF.tsuboi.2008.263">Tsuboi et al 2008</xref>]. Of note, hypoventilation was not reported in one of the ten families with molecularly confirmed Perry syndrome [<xref ref-type="bibr" rid="perry.REF.roy.1988.637">Roy et al 1988</xref>, <xref ref-type="bibr" rid="perry.REF.farrer.2009.163">Farrer et al 2009</xref>].</p>
          <p>Sleep difficulties, a common complaint, reflect hypoventilation.</p>
          <p><bold>Depression.</bold> Psychiatric findings are dominated by apathy, social withdrawal, and &#x0201c;loss of psychic self-activation&#x0201d; (referred to as &#x0201c;athymhormia&#x0201d; in the French literature), although true depression has also been reported.</p>
          <p>One affected individual also presented with frontotemporal dementia-type behavioral manifestations, downward gaze abnormalities, and autonomic dysfunction [<xref ref-type="bibr" rid="perry.REF.newsway.2010.767">Newsway et al 2010</xref>].</p>
          <p><bold>Weight loss.</bold> No anatomic substrate has been reported to account for severe weight loss. Additionally, in most affected individuals weight loss cannot be attributed to significant dysphagia. Weight loss may in fact reflect psychiatric changes; however, mechanisms involving central modification of hunger sensation or an increase in metabolic rate cannot be excluded.</p>
          <p><bold>Autonomic failure.</bold> In one family from Japan with a <italic toggle="yes">DCTN1</italic> pathogenic variant, the four affected individuals displayed early and severe autonomic failure [<xref ref-type="bibr" rid="perry.REF.ohshima.2010.612">Ohshima et al 2010</xref>].</p>
          <p>
            <bold>Neuroimaging</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Structural brain imaging is usually normal.</p>
            </list-item>
            <list-item>
              <p>Functional imaging using 18-fluorodeoxyglucose PET (FDG-PET) showed reduced metabolic rate in the lateral prefrontal and temporal regions in one study [<xref ref-type="bibr" rid="perry.REF.lechevalier.2005.481">Lechevalier et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Dopaminergic pathway functional imaging using 18-fluorodopa PET (FD-PET) showed reduced striatal tracer uptake [<xref ref-type="bibr" rid="perry.REF.perry.1990.1882">Perry et al 1990</xref>, <xref ref-type="bibr" rid="perry.REF.felicio.2014.1197">Felicio et al 2014</xref>]. The tracer reduction uptake was also observed to a lesser extent in an individual with a <italic toggle="yes">DCTN1</italic> pathogenic variant who did not have clinical features of Perry syndrome [<xref ref-type="bibr" rid="perry.REF.felicio.2014.1197">Felicio et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Serotonin transporter imaging using <sup>11</sup>C-3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB-PET) showed reduced tracer uptake in cortical and subcortical regions [<xref ref-type="bibr" rid="perry.REF.felicio.2014.1197">Felicio et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Transcranial sonography showed hyperechogenicity in the substantia nigra comparable to that observed in Parkinson disease [<xref ref-type="bibr" rid="perry.REF.saka.2010.68">Saka et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>In four affected individuals in one family from Japan, decreased cardiac uptake with [123]-metaiodobenzylguanidine scintigram was reported [<xref ref-type="bibr" rid="perry.REF.ohshima.2010.612">Ohshima et al 2010</xref>].</p>
            </list-item>
          </list>
          <p><bold>Neuropathology.</bold> Histology shows severe neuronal loss in the substantia nigra, with no Lewy bodies. Lesser degrees of neuronal loss are found in the locus ceruleus, lentiform nucleus, hypothalamus, periaqueductal gray matter, dorsal raphe nucleus, and brain stem reticular formation [<xref ref-type="bibr" rid="perry.REF.wider.2009.281">Wider et al 2009</xref>]. Specific loss of putative respiratory neurons was demonstrated in the ventrolateral medulla and dorsal raphe nucleus [<xref ref-type="bibr" rid="perry.REF.tsuboi.2008.263">Tsuboi et al 2008</xref>].</p>
          <p>Immunohistochemistry shows ubiquitin- and transactive response DNA-binding protein 43 (TDP-43)-positive neuronal inclusions, dystrophic neurites, glial cytoplasmic inclusions, and axonal spheroids [<xref ref-type="bibr" rid="perry.REF.wider.2009.281">Wider et al 2009</xref>]. TDP-43-positive inclusions predominate in regions belonging to the extrapyramidal system including the substantia nigra, globus pallidus, striatum, and subthalamic nucleus. Interestingly, TDP-43-positive inclusions in persons with Perry syndrome resemble those found in ubiquitin-positive frontotemporal lobar degeneration (FTLD-U) and <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">amyotrophic lateral sclerosis</related-object> (ALS), although with distinct regional distributions.</p>
        </sec>
        <sec id="perry.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Eight pathogenic variants in <italic toggle="yes">DCTN1</italic> have been associated with Perry syndrome (see <xref ref-type="table" rid="perry.T.dctn1_selected_pathogenic_varian">Table 2</xref>) [<xref ref-type="bibr" rid="perry.REF.farrer.2009.163">Farrer et al 2009</xref>, <xref ref-type="bibr" rid="perry.REF.aji.2013.117">Aji et al 2013</xref>, <xref ref-type="bibr" rid="perry.REF.araki.2014.1201">Araki et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.chung.2014.388">Chung et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.tacik.2014.884">Tacik et al 2014</xref>]. No clear genotype-phenotype correlation exists, in that families/individuals with the same pathogenic variant in <italic toggle="yes">DCTN1</italic> do not necessarily share the same phenotype.</p>
          <p>Persons with Perry syndrome may not develop all of the cardinal manifestations. For example, individuals from the same family may not have hypoventilation and weight loss, and others may lack psychiatric symptoms [<xref ref-type="bibr" rid="perry.REF.wider.2010.149">Wider et al 2010</xref>].</p>
        </sec>
        <sec id="perry.Penetrance">
          <title>Penetrance</title>
          <p>Although precise estimates have not been calculated given the limited number of families reported, penetrance is age related and high, with all asymptomatic heterozygotes being younger than or within the range of onset age.</p>
        </sec>
        <sec id="perry.Nomenclature">
          <title>Nomenclature</title>
          <p>Before Perry syndrome became the prevailing term for the disorder, several terms had been used to describe this condition, including hereditary mental depression and parkinsonism with taurine deficiency [<xref ref-type="bibr" rid="perry.REF.perry.1975.108">Perry et al 1975</xref>], familial fatal parkinsonism with alveolar hypoventilation and mental depression [<xref ref-type="bibr" rid="perry.REF.purdy.1979.523">Purdy et al 1979</xref>], familial parkinsonism, apathy, weight loss, and central hypoventilation [<xref ref-type="bibr" rid="perry.REF.roy.1988.637">Roy et al 1988</xref>], dominantly inherited apathy, central hypoventilation, and Parkinson&#x02019;s syndrome [<xref ref-type="bibr" rid="perry.REF.perry.1990.1882">Perry et al 1990</xref>], familial parkinsonism with athymhormia and hypoventilation [<xref ref-type="bibr" rid="perry.REF.lechevalier.1992.39">Lechevalier et al 1992</xref>], familial parkinsonism with depression [<xref ref-type="bibr" rid="perry.REF.bhatia.1993.842">Bhatia et al 1993</xref>], and familial parkinsonism with apathy, depression, and central hypoventilation [<xref ref-type="bibr" rid="perry.REF.elibol.2002">Elibol et al 2002</xref>].</p>
          <p>&#x0201c;Perry syndrome&#x0201d; has appeared in the literature since 2002 [<xref ref-type="bibr" rid="perry.REF.elibol.2002">Elibol et al 2002</xref>]; it is named after Professor Thomas L Perry, who reported the first Canadian family with this disease.</p>
        </sec>
        <sec id="perry.Prevalence">
          <title>Prevalence</title>
          <p>Since the original reports of <xref ref-type="bibr" rid="perry.REF.perry.1975.108">Perry et al [1975]</xref> and <xref ref-type="bibr" rid="perry.REF.perry.1990.1882">Perry et al [1990]</xref>, 21 additional families have been reported from Canada, the United States, the United Kingdom, Japan, France, Turkey, New Zealand, Colombia, Korea, Portugal, and Taiwan [<xref ref-type="bibr" rid="perry.REF.purdy.1979.523">Purdy et al 1979</xref>, <xref ref-type="bibr" rid="perry.REF.roy.1988.637">Roy et al 1988</xref>, <xref ref-type="bibr" rid="perry.REF.lechevalier.1992.39">Lechevalier et al 1992</xref>, <xref ref-type="bibr" rid="perry.REF.tsuboi.2002.1025">Tsuboi et al 2002</xref>, <xref ref-type="bibr" rid="perry.REF.lechevalier.2005.481">Lechevalier et al 2005</xref>, <xref ref-type="bibr" rid="perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</xref>, <xref ref-type="bibr" rid="perry.REF.newsway.2010.767">Newsway et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.ohshima.2010.612">Ohshima et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.saka.2010.68">Saka et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.wider.2010.149">Wider et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.aji.2013.117">Aji et al 2013</xref>, <xref ref-type="bibr" rid="perry.REF.chung.2014.388">Chung et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.pretelt.2014.620">Pretelt et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.tacik.2014.884">Tacik et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.araki.2014.1201">Araki et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.caroppo.2014.208">Caroppo et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.barreto.2015.s304">Barreto et al 2015</xref>, <xref ref-type="bibr" rid="perry.REF.gustavsson.2016.56">Gustavsson et al 2016</xref>].</p>
        </sec>
      </sec>
      <sec id="perry.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Distal hereditary motor neuropathy type VIIB (HMN7B) was associated with a heterozygous p.Gly59Ser <italic toggle="yes">DCTN1</italic> pathogenic variant in affected individuals in one family [<xref ref-type="bibr" rid="perry.REF.puls.2003.455">Puls et al 2003</xref>, <xref ref-type="bibr" rid="perry.REF.puls.2005.687">Puls et al 2005</xref>]<italic toggle="yes">.</italic> Another variant, p.Glu340Gly, has been identified in an individual with inherited peripheral neuropathy; the pathogenicity of this variant remains unclear [<xref ref-type="bibr" rid="perry.REF.nam.2016.382">Nam et al 2016</xref>]. No clinical or pathologic overlap was observed between HMN7B and Perry syndrome [<xref ref-type="bibr" rid="perry.REF.wider.2010.149">Wider et al 2010</xref>]. In HMN7B, the mean age at onset is 34 years (range: 23-44 years); affected individuals present with a lower motor neuron syndrome involving mainly the larynx, face, and upper limbs [<xref ref-type="bibr" rid="perry.REF.puls.2005.687">Puls et al 2005</xref>]. In contrast with Perry syndrome, in which death occurs within ten years, progression in HMN7B is very slow (&#x0003e;30 years in some individuals). Inheritance is autosomal dominant.</p>
        <p><italic toggle="yes">DCTN1</italic> heterozygous pathogenic variants have also been identified in several individuals and families with progressive supranuclear palsy (PSP)-like symptoms, including supranuclear gaze palsy, frequent falls, and eyelid apraxia [<xref ref-type="bibr" rid="perry.REF.newsway.2010.767">Newsway et al 2010</xref>, <xref ref-type="bibr" rid="perry.REF.aji.2013.117">Aji et al 2013</xref>, <xref ref-type="bibr" rid="perry.REF.araki.2014.1201">Araki et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.caroppo.2014.208">Caroppo et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.chung.2014.388">Chung et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.barreto.2015.s304">Barreto et al 2015</xref>, <xref ref-type="bibr" rid="perry.REF.gustavsson.2016.56">Gustavsson et al 2016</xref>]. None of the individuals had pathologically confirmed PSP.</p>
        <p>Pathogenic variants in <italic toggle="yes">DCTN1</italic> appear to be rare in individuals with other neurodegenerative diseases. Several <italic toggle="yes">DCTN1</italic> variants have been identified in individuals with amyotrophic lateral sclerosis (ALS), but none of the variants were considered definite pathogenic variants for various reasons including incomplete segregation, a lack of functional analysis, and the fact that some variants were identified in individuals without ALS [<xref ref-type="bibr" rid="perry.REF.m_nch.2004.724">M&#x000fc;nch et al 2004</xref>, <xref ref-type="bibr" rid="perry.REF.m_nch.2005.777">M&#x000fc;nch et al 2005</xref>, <xref ref-type="bibr" rid="perry.REF.takahashi.2008.1326">Takahashi et al 2008</xref>, <xref ref-type="bibr" rid="perry.REF.vilari_og_ell.2009.2024">Vilari&#x000f1;o-G&#x000fc;ell et al 2009</xref>, <xref ref-type="bibr" rid="perry.REF.stockmann.2013.785">Stockmann et al 2013</xref>, <xref ref-type="bibr" rid="perry.REF.liu.2014.2881.e11">Liu et al 2014</xref>, <xref ref-type="bibr" rid="perry.REF.cady.2015.100">Cady et al 2015</xref>].</p>
      </sec>
      <sec id="perry.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other forms of familial early-onset parkinsonism that need to be distinguished from Perry syndrome include those types caused by mutation of <italic toggle="yes">PRKN</italic> (<italic toggle="yes">PARK2</italic>) (see <related-object link-type="booklink" source-id="gene" document-id="jpd" document-type="chapter">Parkin Type of Early-Onset Parkinson Disease</related-object>)<italic toggle="yes">, PINK1</italic> (see <related-object link-type="booklink" source-id="gene" document-id="pink1-pd" document-type="chapter"><italic toggle="yes">PINK1</italic> Type of Young-Onset Parkinson Disease</related-object>), <italic toggle="yes">PARK7</italic> (formerly <italic toggle="yes">DJ-1</italic>), or <italic toggle="yes">LRRK2</italic> (see <related-object link-type="booklink" source-id="gene" document-id="lrrk2" document-type="chapter"><italic toggle="yes">LRRK2</italic>-Related Parkinson Disease</related-object>). The findings of personality changes, weight loss, and hypoventilation in Perry syndrome tend to distinguish it from other forms of early-onset Parkinson disease (see <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>). Additionally, response to standard doses of levodopa is usually poorer or of shorter duration in Perry syndrome than in other forms of early-onset Parkinson disease.</p>
        <p>Mood/personality changes in Perry syndrome may suggest frontotemporal dementia, which has a similar age of onset and is often associated with levodopa-resistant parkinsonism.</p>
        <p>Perry syndrome needs to be distinguished from frontotemporal dementia caused by mutation of <italic toggle="yes">MAPT</italic> (see <related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter"><italic toggle="yes">MAPT</italic>-Related Disorders</related-object>) or <italic toggle="yes">GRN</italic> (see <related-object link-type="booklink" source-id="gene" document-id="ftd-grn" document-type="chapter"><italic toggle="yes">GRN</italic>-Related Frontotemporal Dementia</related-object>). An individual of Japanese ancestry who showed symptoms reminiscent of Perry syndrome was found to have an <italic toggle="yes">MAPT</italic> pathogenic variant. On autopsy examination, the brain showed tau-positive inclusions; transactive response DNA-binding protein 43 (TDP-43)-positive inclusions were not present [<xref ref-type="bibr" rid="perry.REF.omoto.2012.762">Omoto et al 2012</xref>].</p>
      </sec>
      <sec id="perry.Management">
        <title>Management</title>
        <sec id="perry.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Perry syndrome the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic evaluation of motor function</p>
            </list-item>
            <list-item>
              <p>Sleep study and evaluation by a pulmonologist or sleep disorders consultant for ventilation support if required</p>
            </list-item>
            <list-item>
              <p>Psychiatric evaluation and (if needed) neuropsychological examination</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="perry.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Parkinsonism.</bold> Dopaminergic therapy (particularly carbidopa/levodopa) should be considered in all individuals with significant parkinsonism. Response to levodopa is usually absent, erratic, or transient in Perry syndrome [<xref ref-type="bibr" rid="perry.REF.tsuboi.2002.1025">Tsuboi et al 2002</xref>, <xref ref-type="bibr" rid="perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</xref>]. However, large doses of carbidopa/levodopa (&#x0003e;2g) have been used successfully to reduce rigidity, tremor, and other symptoms in two individuals, one from the new British kindred [<xref ref-type="bibr" rid="perry.REF.newsway.2010.767">Newsway et al 2010</xref>] and one from the original Canadian family [J Stoessl, personal communication].</p>
          <p><bold>Hypoventilation.</bold> Ventilation support (invasive or noninvasive) may prolong life expectancy and have a significant impact on quality of life. Several persons without evidence of daytime central hypoventilation or respiratory troubles died suddenly at night most likely as a result of nocturnal hypoventilation. Therefore, ventilation support may be needed only during sleep [Wider &#x00026; Wszolek, personal observation]. A bilateral diaphragmatic pacemaker may help combat respiratory insufficiency [<xref ref-type="bibr" rid="perry.REF.pretelt.2014.620">Pretelt et al 2014</xref>].</p>
          <p><bold>Depression.</bold> Psychiatric manifestations may require antidepressants and psychiatric follow up to help reduce risk of suicide.</p>
          <p><bold>Weight loss.</bold> Careful weight follow up is indicated and high caloric intake should be considered if weight loss is present.</p>
        </sec>
        <sec id="perry.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Adequate caloric intake must be ensured to prevent weight loss.</p>
        </sec>
        <sec id="perry.Surveillance">
          <title>Surveillance</title>
          <p>Routine evaluation of weight and calorie intake, respiratory function (particularly at night or during sleep), motor function, and mood/personality changes is appropriate.</p>
        </sec>
        <sec id="perry.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Use of central respiratory depressants (e.g., benzodiazepines, alcohol, narcotics) should be minimized.</p>
        </sec>
        <sec id="perry.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="perry.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="perry.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="perry.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="perry.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Perry syndrome is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="perry.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals diagnosed with Perry syndrome usually have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with Perry syndrome may have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">DCTN1</italic> pathogenic variant. Because simplex cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if the pathogenic variant was <italic toggle="yes">de novo</italic>, the proportion of Perry syndrome caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include clinical and genetic evaluations. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
            <list-item>
              <p>Note: Although most individuals diagnosed with Perry syndrome have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected and/or has a <italic toggle="yes">DCTN1</italic> pathogenic variant, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for Perry syndrome because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low, but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with Perry syndrome has a 50% chance of inheriting the <italic toggle="yes">DCTN1</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected and/or has a <italic toggle="yes">DCTN1</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="perry.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with Perry syndrome is possible after molecular genetic testing has identified the specific <italic toggle="yes">DCTN1</italic> pathogenic variant in the family. Such testing should be performed in the context of formal genetic counseling. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>It is appropriate to consider testing symptomatic individuals regardless of age in a family with an established diagnosis of Perry syndrome.</p>
          <p>For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">Position Statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/pediatrics/131/3/620.full.pdf">Policy Statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="perry.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">DCTN1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for Perry syndrome are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="perry.Resources">
        <title>Resources</title>
      </sec>
      <sec id="perry.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="perry.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">DCTN1</italic> encodes p150<sup>(glued)</sup>, the major subunit of the dynactin protein complex [<xref ref-type="bibr" rid="perry.REF.farrer.2009.163">Farrer et al 2009</xref>]. The dynactin protein complex plays a major role in retrograde axonal and cytoplasmic transport of vesicles, organelles, and other cargos through binding to its complex structure. p150(glued) contains the cytoskeleton-associated protein glycine-rich (CAP-Gly) domain that is essential for microtubule binding. All <italic toggle="yes">DCTN1</italic> variants found in individuals with Perry syndrome are located in this domain. In vitro, <italic toggle="yes">DCTN1</italic> variants alter the ability of dynactin to bind microtubules, thereby impairing its function as a transport protein [<xref ref-type="bibr" rid="perry.REF.puls.2003.455">Puls et al 2003</xref>, <xref ref-type="bibr" rid="perry.REF.levy.2006.733">Levy et al 2006</xref>, <xref ref-type="bibr" rid="perry.REF.farrer.2009.163">Farrer et al 2009</xref>, <xref ref-type="bibr" rid="perry.REF.lloyd.2012.344">Lloyd et al 2012</xref>, <xref ref-type="bibr" rid="perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</xref>].</p>
          <p>The link between <italic toggle="yes">DCTN1</italic> pathogenic variants and neuronal dysfunction/death remains to be elucidated. For example, the fact that pathogenic variants causing Perry syndrome and HMN7B are located close to each other yet cause completely different clinical features with distinct distribution of affected neuronal systems constitutes a challenging puzzle [<xref ref-type="bibr" rid="perry.REF.wider.2010.149">Wider et al 2010</xref>].</p>
          <p><bold>Gene structure.</bold> Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. The reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004082.3">NM_004082.3</ext-link> is known as isoform 1; details of other isoforms are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gene/1639">Entrez Gene</ext-link>.</p>
          <p><bold>Pathogenic variants.</bold> All reported Perry syndrome-associated pathogenic variants in <italic toggle="yes">DCTN1</italic> are missense variants. These variants induce a loss of CAP-Gly function. The p.Gly71Arg variant has a dominant-negative effect on initiation of retrograde transport [<xref ref-type="bibr" rid="perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</xref>].</p>
          <table-wrap id="perry.T.dctn1_selected_pathogenic_varian" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">DCTN1</italic> Selected Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.156T&#x0003e;G</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe52Leu</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_3" rowspan="10" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004082.4">NM_004082.4</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004073.2">NP_004073.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.167A&#x0003e;G</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys56Arg&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.175G&#x0003e;A</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly59Ser&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.200G&#x0003e;A</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly67Asp</td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.211G&#x0003e;A</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly71Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.212G&#x0003e;A</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly71Glu</td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.212G&#x0003e;C</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly71Ala</td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.214A&#x0003e;C</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr72Pro</td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.221A&#x0003e;C</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln74Pro</td>
                </tr>
                <tr>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.233A&#x0003e;G</td>
                  <td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr78Cys</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="perry.TF.2.1">
                <label>1. </label>
                <p>This pathogenic variant has been identified in individuals with clinical PSP (no autopsy confirmation).</p>
              </fn>
              <fn id="perry.TF.2.2">
                <label>2. </label>
                <p>This pathogenic variant causes HMN7B.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">DCTN1</italic> encodes p150<sup>(glued)</sup>, the major subunit of the dynactin protein complex, which plays an important role in axonal and cytoplasmic transport.</p>
          <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">DCTN1</italic> harboring single-nucleotide variants that cause Perry syndrome and HMN7B encodes abnormal forms of p150<sup>(glued)</sup>, which alter the affinity of dynactin for microtubules. Pathogenic variants associated with Perry syndrome are exposed to the surface of the CAP-Gly domain of p150<sup>(glued)</sup> [<xref ref-type="bibr" rid="perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</xref>]. This abnormal p150<sup>(glued)</sup> fails to accumulate dynactin at the neurite tip, resulting in disruption of retrograde flux [<xref ref-type="bibr" rid="perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</xref>].</p>
        </sec>
      </sec>
      <sec id="perry.References">
        <title>References</title>
        <sec id="perry.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="perry.Literature_Cited.reflist0">
            <ref id="perry.REF.aji.2013.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aji</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medley</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Driscoll</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larner</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alusi</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Perry syndrome: a disorder to consider in the differential diagnosis of Parkinsonism.</article-title>
                <source>J Neurol Sci</source>
                <volume>330</volume>
                <fpage>117</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23628468</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.araki.2014.1201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daechsel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milnerwood</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarino-Guell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mishima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukae</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy.</article-title>
                <source>Mov Disord</source>
                <volume>29</volume>
                <fpage>1201</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24676999</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.barreto.2015.s304">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barreto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roriz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magalh&#x000e3;es</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Perry syndrome &#x02013; Characteristics of the first Portuguese family.</article-title>
                <source>Mov Disord</source>
                <volume>30</volume>
                <fpage>S304</fpage>
                <lpage>5</lpage>
              </element-citation>
            </ref>
            <ref id="perry.REF.bhatia.1993.842">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniel</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>CD</given-names>
                  </name>
                </person-group>
                <article-title>Familial parkinsonism with depression: a clinicopathological study.</article-title>
                <source>Ann Neurol.</source>
                <year>1993</year>
                <volume>34</volume>
                <fpage>842</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8250534</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.cady.2015.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cady</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allred</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bali</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitra</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravits</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harms</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes.</article-title>
                <source>Ann Neurol</source>
                <volume>77</volume>
                <fpage>100</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">25382069</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.caroppo.2014.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caroppo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivaud-P&#x000e9;choux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Septenville</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutoleau-Bretonni&#x000e8;re</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mourlon</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sauv&#x000e9;e</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebouvier</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vercelletto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2014</year>
                <article-title>DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes.</article-title>
                <source>JAMA Neurol</source>
                <volume>71</volume>
                <fpage>208</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">24343258</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.chung.2014.388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ji</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoo</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>YJ</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Expansion of the clinicopathological and mutational spectrum of Perry syndrome.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>20</volume>
                <fpage>388</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">24484619</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.elibol.2002">
              <mixed-citation publication-type="book">Elibol B, Kobayashi T, Atac FB, Hattori N, Sahin G, Gurer G. Familial parkinsonism with apathy, depression and central hypoventilation (Perry's syndrome). In: Mizuno Y, ed. <italic toggle="yes">Mapping the Progress of Alzheimer's and Parkinson's Disease.</italic> Boston, MA: Kluwer Academic/Plenum Publishers; 2002:285-90.</mixed-citation>
            </ref>
            <ref id="perry.REF.farrer.2009.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e4;chsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grantier</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lechevalier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutmann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elibol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilari&#x000f1;o-G&#x000fc;ell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castanedes-Casey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>DCTN1 mutations in Perry syndrome.</article-title>
                <source>Nat Genet.</source>
                <volume>41</volume>
                <fpage>163</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19136952</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.felicio.2014.1197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Felicio</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinelle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agarwal</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenzie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heffernan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Road</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appel-Cresswell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sossi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers.</article-title>
                <source>Mov Disord</source>
                <volume>29</volume>
                <fpage>1197</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">24797316</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.gustavsson.2016.56">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gustavsson</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trinh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guella</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szu-Tu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khinda</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appel-Cresswell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeown</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeon</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>DCTN1 p.K56R in progressive supranuclear palsy.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>28</volume>
                <fpage>56</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">27132499</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.lechevalier.2005.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lechevalier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivrain</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Doze</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schupp</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viader</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Perry and Purdy's syndrome (familial and fatal parkinsonism with hypoventilation and athymhormia)</article-title>
                <source>Bull Acad Natl Med.</source>
                <volume>189</volume>
                <fpage>481</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">16149212</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.lechevalier.1992.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lechevalier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schupp</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fallet-Bianco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viader</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eustache</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morin</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Familial parkinsonian syndrome with athymhormia and hypoventilation.</article-title>
                <source>Rev Neurol</source>
                <volume>148</volume>
                <fpage>39</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">1604112</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.levy.2006.733">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumner</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caviston</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokito</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranganathan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligon</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaMonte</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harmison</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puls</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holzbaur</surname>
                    <given-names>EL</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation.</article-title>
                <source>J Cell Biol</source>
                <volume>172</volume>
                <fpage>733</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">16505168</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.liu.2014.2881.e11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>ZJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tao</surname>
                    <given-names>QQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>XW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiong</surname>
                    <given-names>ZQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>ZY</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system.</article-title>
                <source>Neurobiol Aging</source>
                <volume>35</volume>
                <fpage>2881.e11</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25109764</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.lloyd.2012.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Machamer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Hara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imlach</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levitan</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCabe</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodkin</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>The p150(Glued) CAP-Gly domain regulates initiation of retrograde transport at synaptic termini.</article-title>
                <source>Neuron</source>
                <volume>74</volume>
                <fpage>344</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">22542187</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.moughamian.2012.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moughamian</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holzbaur</surname>
                    <given-names>EL</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Dynactin is required for transport initiation from the distal axon.</article-title>
                <source>Neuron</source>
                <volume>74</volume>
                <fpage>331</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">22542186</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.m_nch.2004.724">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;nch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedlmeier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Homberg</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperfeld</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prudlo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peraus</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanemann</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumm</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>724</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15326253</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.m_nch.2005.777">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;nch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenbohm</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperfeld</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uttner</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedlmeier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanemann</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumm</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.</article-title>
                <source>Ann Neurol</source>
                <volume>58</volume>
                <fpage>777</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16240349</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.nam.2016.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nam</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>YB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyun</surname>
                    <given-names>YS</given-names>
                  </name>
                </person-group>
                <article-title>Nam da E, Kwak G, Hwang SH, Choi BO, Chung KW. Identification of Genetic Causes of Inherited Peripheral Neuropathies by Targeted Gene Panel Sequencing.</article-title>
                <source>Mol Cells.</source>
                <year>2016</year>
                <volume>39</volume>
                <fpage>382</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">27025386</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.newsway.2010.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newsway</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fish</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohrer</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majounie</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hack</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <article-title>Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure.</article-title>
                <source>Mov Disord.</source>
                <year>2010</year>
                <volume>25</volume>
                <fpage>767</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">20437543</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.ohshima.2010.612">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohshima</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kira</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shii</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Autonomic failures in Perry syndrome with DCTN1 mutation.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2010</year>
                <volume>16</volume>
                <fpage>612</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20702129</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.omoto.2012.762">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Omoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogasawara</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koga</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanda</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Autosomal dominant tauopathy with parkinsonism and central hypoventilation.</article-title>
                <source>Neurology</source>
                <volume>78</volume>
                <fpage>762</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22357714</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.perry.1975.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bratty</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urquhart</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dolman</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>1975</year>
                <article-title>Hereditary mental depression and Parkinsonism with taurine deficiency.</article-title>
                <source>Arch Neurol</source>
                <volume>32</volume>
                <fpage>108</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">1122173</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.perry.1990.1882">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>TL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases.</article-title>
                <source>Neurology</source>
                <volume>40</volume>
                <fpage>1882</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">2247238</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.pretelt.2014.620">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pretelt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casta&#x000f1;eda Cardona</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tacik</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <article-title>Latin America's first case of Perry syndrome and a new treatment option for respiratory insufficiency.</article-title>
                <source>J Neurol.</source>
                <year>2014</year>
                <volume>261</volume>
                <fpage>620</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">24500497</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.puls.2003.455">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puls</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonnakuty</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaMonte</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holzbaur</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Floeter</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bidus</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drayna</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Ludlow</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutant dynactin in motor neuron disease.</article-title>
                <source>Nat Genet</source>
                <volume>33</volume>
                <fpage>455</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12627231</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.puls.2005.687">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puls</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumner</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Floeter</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wendelschafer-Crabb</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vortmeyer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finnegan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holzbaur</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludlow</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Distal spinal and bulbar muscular atrophy caused by dynactin mutation.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>687</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">15852399</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.purdy.1979.523">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Purdy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnett</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bratty</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGeer</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>TL</given-names>
                  </name>
                </person-group>
                <year>1979</year>
                <article-title>Familial fatal Parkinsonism with alveolar hypoventilation and mental depression.</article-title>
                <source>Ann Neurol</source>
                <volume>6</volume>
                <fpage>523</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">43704</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.roy.1988.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roy</surname>
                    <given-names>EP</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Riggs</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringel</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutmann</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management.</article-title>
                <source>Neurology</source>
                <volume>38</volume>
                <fpage>637</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">3352925</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.saka.2010.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcuoglu</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demir</surname>
                    <given-names>AU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elibol</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Transcranial sonography in Perry syndrome.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>16</volume>
                <fpage>68</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19505837</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.stockmann.2013.785">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stockmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer-Ohlendorf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Achberger</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Putz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demestre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrich</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proepper</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuh</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwalenst&#x000f6;cker</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braunstein</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Arnim</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneuwly</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boeckers</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebau</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes.</article-title>
                <source>J Neural Transm</source>
                <volume>120</volume>
                <fpage>785</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">23143281</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.tacik.2014.884">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tacik</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiesel</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujioka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pretelt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casta&#x000f1;eda Cardona</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kidd</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hlavac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raizis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okun</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traynor</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strongosky</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Springer</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <article-title>Three families with Perry syndrome from distinct parts of the world.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2014</year>
                <volume>20</volume>
                <fpage>884</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24881494</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.takahashi.2008.1326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsui</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsukawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimozawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis</article-title>
                <year>2008</year>
                <source>Arch Neurol</source>
                <volume>65</volume>
                <fpage>1326</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">18852346</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.tsuboi.2008.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabeshima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmeichel</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benarroch</surname>
                    <given-names>EE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Neurodegeneration involving putative respiratory neurons in Perry syndrome.</article-title>
                <source>Acta Neuropathol</source>
                <volume>115</volume>
                <fpage>263</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17576579</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.tsuboi.2002.1025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kusuhara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doh-ura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Japanese family with parkinsonism, depression, weight loss, and central hypoventilation.</article-title>
                <source>Neurology</source>
                <volume>58</volume>
                <fpage>1025</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">11940687</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.vilari_og_ell.2009.2024">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vilari&#x000f1;o-G&#x000fc;ell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soto-Ortolaza</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobb</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keeling</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dachsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graff-Radford</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boeve</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Josephs</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boylan</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gwinn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adler</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dest&#x000e9;e</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krygowska-Wajs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chartier-Harlin</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Characterization of DCTN1 genetic variability in neurodegeneration.</article-title>
                <source>Neurology</source>
                <year>2009</year>
                <volume>72</volume>
                <fpage>2024</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19506225</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.wider.2010.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dachsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Elucidating the genetics and pathology of Perry syndrome.</article-title>
                <source>J Neurol Sci</source>
                <volume>289</volume>
                <fpage>149</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">19732908</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.wider.2009.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutmann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lechevalier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Personett</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grantier</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sujith</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pallidonigral TDP-43 pathology in Perry syndrome.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>15</volume>
                <fpage>281</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18723384</pub-id>
              </element-citation>
            </ref>
            <ref id="perry.REF.wider.2008.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature review.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>14</volume>
                <fpage>1</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17870652</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="perry.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="perry.Acknowledgments">
          <title>Acknowledgments</title>
          <p>Dr Wszolek is supported by NIH/NINDS P50NS072187, NIH/NIA (primary) and NIH/NINDS (secondary) 1U01AG045390-01A1, Mayo Center for Regenerative Medicine, Mayo Clinic Neuroscience Focused Research Team (Cecilia and Dan Carmichael Family Foundation, and the James C and Sarah K Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida), and The Sol Goldman Charitable Trust.</p>
          <p>Dr Konno is supported by the JSPS Postdoctoral Fellowship for Research Abroad, and the gift from Carl Edward Bolch, Jr and Susan Bass Bolch.</p>
        </sec>
        <sec id="perry.Author_History">
          <title>Author History</title>
          <p>Takuya Konno, MD (2016-present)Christian Wider, MD; Centre Hospitalier Universitaire Vaudois, Lausanne (2010-2016)Zbigneiw Wszolek, MD (2010-present)</p>
        </sec>
        <sec id="perry.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 September 2016 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 May 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 September 2010 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>3 May 2010 (cw) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
